3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase 3
2
Phase NA
1
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Breast Neoplasms
10
Prostatic Neoplasms
8
Brain Neoplasms
7
Head and Neck Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Carcinoma, Intraductal, Noninfiltrating
4
Uterine Cervical Neoplasms
3
Neoplasms
3
Lung Neoplasms
3
Glioblastoma
3
Esophageal Neoplasms
3
Endometrial Neoplasms
3
Oropharyngeal Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Glioma
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Carcinoma, Ductal, Breast
2
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Tonsillar Neoplasms
1
Symptomatic Osseous Bone Lesions From Any Malignancy
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Skin Diseases
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Interventions
Cyclophosphamide
21
fludarabine phosphate
13
Cyclosporine
11
Antilymphocyte Serum
11
Peripheral Blood Stem Cell Transplantation
10
Methotrexate
10
Busulfan
10
Cytarabine
9
Filgrastim
8
Radiotherapy
7
Dexamethasone
7
Whole-Body Irradiation
6
Mycophenolic Acid
6
Methylprednisolone
6
Melphalan
6
Exercise
6
fludarabine
5
Vincristine
5
Daunorubicin
5
Cord Blood Stem Cell Transplantation
5
pegaspargase
4
Rituximab
4
Palliative Care
4
Mercaptopurine
4
Etoposide
4
Early Intervention, Educational
4
Blood Specimen Collection
4
Asparaginase
4
Alemtuzumab
4
Thioguanine
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Leukemia
×
Radiation
×
Clear all
NCT00578539
2016-04-22
REGALE
Baylor College of Medicine
Phase NA
Terminated
24 enrolled
7 charts